|
Market Cap (5-Jun) $3,159,507 (1,963rd) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 42,322 |
Shortsold (5-Apr) 9,554 (0.01%) (569th) |
|
52w High $0.020 |
52w Low $0.005 |
P/E - |
EPS -0.01 |
ANR released this announcement to the ASX on 18 August 2021, 8:29. The announcement is not marked as price sensitive, and is 26 page(s) in length and 624.03kb in size.
You can view all announcements from ANR and see how they appear on a price chart on the announcements page.
At the date of this announcement, NUH was 0.003% short sold according to ASIC data. It was ranked the 598th most shorted stock on the ASX. It is now ranked as the 569th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (05 April 2024).
| Other Recent Announcements from ANR | |
|---|---|
| Anatara Update on GaRP Irritable Bowel Syndrome Trial | 6 June 2023, 8:19 |
| Anatara Investor Presentation | 8 May 2023, 10:44 |
| Registered Office Change | 20 April 2023, 11:51 |
| Appendix 4G and Corporate Governance Statement | 18 August 2021, 8:29 |
| Notification regarding unquoted securities - ANR | 17 August 2021, 8:21 |
| Application for quotation of securities - ANR | 17 August 2021, 8:20 |
| Successful Piglet Study | 6 August 2021, 9:02 |
You must be logged in to post a reply.
Anatara Lifesciences 